Status:
TERMINATED
Glaucoma Eye Drop Instillation: Impact of Education
Lead Sponsor:
Northwestern University
Conditions:
Glaucoma, Open-Angle
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
The purpose of this study is to assess whether an educational intervention will have a positive effect on patients' ability to properly administer eye drops. The investigators predict that the educati...
Detailed Description
Glaucoma is a leading cause of irreversible vision loss worldwide, and as such has a large public health impact. The only treatment proven to slow or arrest the progression of the disease process is i...
Eligibility Criteria
Inclusion
- Established care with the treating ophthalmologist for at least 6 months
- Diagnosis of open-angle glaucoma or ocular hypertension
- The use of one, two or three self-instilled eye drop medications in one or two eyes
- Age 40-85 years
- Fluency in English
- Best corrected visual acuity (BCVA) of 20/50 or better in each eye
Exclusion
- Presence of moderate to severe cognitive deficits
- Presence of a clinically significant tremor
- Mini Mental Status Exam score ≤ 20
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01416415
Start Date
August 1 2011
End Date
June 1 2013
Last Update
April 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medical Faculty Foundation
Chicago, Illinois, United States, 60611